Faron Pharmaceuticals Oy Share Discussion Threads

[bauchsapt] 21/5/2018 18:51

Superg1 how's vrs doing over there mate?

[fairlight] 21/5/2018 14:22

superg1 - not sure I totally agree with you, I don't think it's a bad gamble from this level.

If they find the trial was completed correctly the company has Clevegen and other possible areas of treatment where Traumakine could be effective.

OK it would not be good but down side would be 50% maybe? - however they seemed pretty confident about Traumakine until the Phase 3 study and the BoD bought loads of shs at £8+ they also seemed very surprised with the result of the P3 trial.

So IMO downside 50% and upside (if the P3 trial was administered incorrectly) initially 100-200% and longer term (if it proves successful in Japan) more.

I like the odds myself.

[papillon] 18/5/2018 16:11

kirk 6 17 May '18 - 22:11 - 420 of 426

Haha how are you mate? I’ve made a fortune on these pharma crashes

This one will Bounce hard to well Over £2

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

Congratulations on making "a fortune on these pharma crashes". It's often the case that there is a dead cat bounce after such a steep fall on such bad news. For FARN the "bounce" was large percentage wise and no doubt clever gamblers like your goodself could easily have made a 50% profit on your money within a day, or two. However that "bounce" is finished and I can't see your £2 target being achieved anytime soon (if at all). Still no doubt you have made your money and departed to pastures new. Perhaps your next gamble will be loss making? Though I doubt you will boast about that!

[piperpeter] 18/5/2018 11:45

REDX picking up again.

Lisa Anson, Senior AstraZeneca Executive and President of AstraZeneca UK since 2012, appointed CEO of REDX, takes up the post from June 1 2018.

Pp.

[craigo121] 18/5/2018 10:55

Kurks jumped ship already WEB primed for 10 bagger with this news can only go one way now 100p by AUGUST

[shirley83] 18/5/2018 09:01

Hey kirk.. WEB about to go BOOOOMM

[craigo121] 18/5/2018 08:52

Remember this was a phase 111 trial failure would take a lot of new research and new funding in order to evaluate# having burnt 20 million to find the drugs no better than a placebo when they come cap in hand again! are you willing to take the risks#

All is not lost there is still other development's ie clevegen(5 million research) but that would 9nly rate the share at a fraction of what they were

[craigo121] 18/5/2018 08:51

Remember this was a phase 111 trial failure would take a lot of new research and new funding in order to evaluate# having burnt 20 million to find the drugs no better than a placebo when they come cap in hand again! are you willing to take the risks#

All is not lost there is still other development's ie clevegen(5 million research) but that would 9nly rate the share at a fraction of what they were

[craigo121] 18/5/2018 06:51

You can have these shares by the truck load: L2 has a Q of institutional shares ready to dump there's no real support line just a downward spiral back to 60p

[kirk 6] 17/5/2018 22:11

Haha how are you mate? I've made a fortune on these pharma crashes This one will Bounce hard to well Over £2

[immy1992] 17/5/2018 17:50

Why would you go balls deep on a p3 drug that showed it's no better if not worse then placebo ?!?!

[ernestsyngen] 17/5/2018 13:22

Just gone " Balls Deep" as i feel this is the bottom. The potential gain is far more than the right off value of my investment.

Lets get some good news RNS in now

[craigo121] 17/5/2018 12:53

This is POISED awaiting better news than a director picking up pocket change of shares

Unfortunately any news whether good/bad will be over 1 year until the next trial is collaberated# anyone holding looking for a quick buck better have a get out plan as this shares going to be played about with the MM's for fun#
The shares worthless without the licence and that's a million miles away right now!
Good luck if you hold

[kirk 6] 16/5/2018 21:34

Great news

[immy1992] 16/5/2018 20:49

Oh please. Let me know when a director buys more then half his or her monthly salaries worth.

[jayj4u] 16/5/2018 19:53

DIRECTOR BUYING!!!

15 May 2018 Dr Jonathan Knowles, a Non-Executive Director of Faron has acquired 7,200 ordinary shares in Faron at an average price of 118.00 pence per ordinary share and 1,300 ordinary shares in Faron at an average price of 116.97 pence per ordinary share.

[haveapunt1] 16/5/2018 19:27

Good old Craigo121, caught with his pants down again on a day trade or short. As usual no facts just rubbish one liners to. Come on old boy add some real meat to your c r a p

[spawny100] 16/5/2018 17:50

Same crew moved on to pump this after IMM. Seem to specialise in failed P3 trials....

[kirk 6] 16/5/2018 17:48

Looking like this will hit £2 before week is out as momentum gathers to the upside

[craigo121] 16/5/2018 17:09

Primed to test 105 tomm watch the drop

[superg1] 16/5/2018 14:43

KoP

Funny you should mention that I thought one line was and insensitive to say the least.

CEO opening line.

"We are incredibly disappointed and surprised by these results.

The next line has this in it

and in the unusually low mortality rate observed in the placebo arm.

Very poor form to mix the two in the same paragraph.

[kop202] 16/5/2018 13:09

Kirk please enlighten my darkness and tell why do you think Faron is still worth a punt?